Axsome Therapeutics Inc

NAS:AXSMHealthcareNASDAQ:NBINASDAQ:NQUSMG

$155.81−0.85%At closeAt close · Tue 20 Oct · ≈ AED 572.21 · Market cap $8.16B · Next earnings Mon 2 Nov · Extended $155.75 −0.04%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	89.6%	90.4%	91.4%	92.6%	—	—
Operating margin	—	—	−359.3%	−85.7%	−72.7%	−26.5%	−26.5%	+0.0 pts
Net margin	—	—	−374.0%	−88.4%	−74.5%	−28.7%	−28.7%	+0.0 pts
EBITDA margin	—	—	−350.5%	−83.1%	−70.7%	−26.3%	—	—
Return on equity	−90.4%	−834.3%	−170.8%	−125.3%	−503.8%	−207.5%	−207.5%	+0.0 pts
Return on assets	−55.3%	−148.5%	−56.5%	−40.7%	−50.5%	−26.6%	−26.6%	+0.0 pts
Return on capital employed	−60.9%	−192.7%	−76.5%	−51.6%	−82.9%	−54.4%	—	—
Debt / equity	0.4×	3.2×	0.9×	1.0×	3.4×	2.7×	2.7×	+0.0%
Debt / assets	26.9%	56.6%	28.6%	31.7%	33.9%	35.0%	—	—
Interest coverage	−38.6×	−21.9×	−24.5×	−35.9×	−42.7×	−25.8×	—	—
Current ratio	7.9×	3.8×	2.5×	3.6×	2.1×	1.6×	1.6×	+0.0%
Quick ratio	7.9×	3.8×	2.5×	3.5×	2.0×	1.5×	—	—
Cash ratio	7.8×	3.7×	2.1×	2.8×	1.4×	0.9×	0.9×	+0.0%
Asset turnover	0.0×	0.0×	0.2×	0.5×	0.7×	0.9×	—	—
Inventory turnover	—	—	1.2×	1.7×	2.1×	1.7×	—	—
Receivables turnover	—	—	1.3×	2.9×	2.7×	2.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.